Guru Ownership Trend
Guru Analysis for Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (TERN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $50.37 M.
Top institutional holders include George Soros and Paul Tudor Jones.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $4.52 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 281.6%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 63.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Terns Pharmaceuticals, Inc. (TERN)
Major holders include George Soros ($16.97 M), Paul Tudor Jones ($14.1 M), Cliff Asness ($9.32 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 951,729 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $4.52 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited TERN. The total reported sell value was $38.88 M.
Yes, 1 managers opened new positions in TERN, and 3 increased their existing holdings. The total reported buy value was $34.35 M.